Industries > Pharma > Global Anaesthesia Drugs Market 2019-2029

Global Anaesthesia Drugs Market 2019-2029

Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others

PUBLISHED: 19 March 2019
PAGES: 241
PRODUCT CODE: PHA0358

Clear
WOOCS 2.2.1
SKU: PHA0358 Categories: , , Tags: ,

The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Anaesthesia Drugs Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
• Local Anaesthesia Drugs
• General Anaesthesia Drugs

• This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
• Benzocaine
• Bupivacaine
• Chloroprocaine
• Lidocaine
• Prilocaine
• Ropivacaine
• Others

• This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
• Desflurane
• Dexmedetomidine
• Midazolam
• Propofol
• Remifentanil
• Sevoflurane
• Others

• This report shows forecasts to 2029 for the market segmented by route of administration:
• Inhalation Anaesthesia Drugs
• Intravenous Anaesthesia Drugs
• Topical Anaesthesia Drugs

• Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
• North America: US and Canada
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• RoW: Brazil, Mexico, Russia, South Africa

Global Anaesthesia Drugs Market 2019-2029

Each regional and national market is further segmented by type, drug and route of administration.

• This report discusses these selected leading companies:
• Baxter International, Inc.
• AbbVie
• PAION AG
• Pfizer
• Hameln Pharmaceuticals
• AstraZeneca
• Fresenius Kabi
• Maruishi Pharmaceuticals
• Pacira Pharmaceuticals, Inc

Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.

• This report discusses promising drug candidates which are under development for the anaesthesia drugs market.

• Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.

Visiongain’s study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions.

Buy our report today Anaesthesia Drugs Market Analysis : Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia, Benzocaine, Bupivacaine, Chloroprocaine, Lidocaine, Prilocaine, Ropivacaine, Desflurane, Dexmedetomidine, Midazolam, Propofol, Remifentanil, Sevoflurane and Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Anaesthesia Drugs Market 2019-2029


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories